Vir Biotechnology (VIR) Pension (2019 - 2020)

Vir Biotechnology's (VIR) quarterly Pension came in at $2.9 million in Q4 2020, up 52.63% year-on-year from $1.9 million in Q1 2020, and up 52.63% quarter-over-quarter from $1.9 million in Q4 2019.

Vir Biotechnology (VIR) Pension (2019 - 2020) Analysis & Trends

Vir Biotechnology has disclosed Pension across 2 years of filings, most recently posting $2.9 million for Q4 2020.

  • Pension for Q4 2020 came in at $2.9 million, up 52.63% year-over-year; the trailing twelve-month figure through Dec 2020 was $2.9 million (up 52.63% YoY), and the FY2020 annual result was $2.9 million, up 52.63% from the prior year.
  • Pension came in at $2.9 million for Q4 2020 at Vir Biotechnology, up from $1.9 million in the prior quarter.
  • In the past five years, Pension ranged from a high of $2.9 million in Q4 2020 to a low of $1.9 million in Q4 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Vir Biotechnology 1.35 Bn 1.35 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2020 2.90 Mn
Dec 31, 2019 1.90 Mn